Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

John P. Palmer; Arief A. Suriawinata; Shaofeng Yan; Darcy A. Kerr; Muhammad Z. Afzal; Keisuke Shirai

doi:10.12659/AJCR.938537

18 November 2023 : Case report USA

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Unusual or unexpected effect of treatment

John P. Palmer^1ADEF*, Arief A. Suriawinata^2BDE, Shaofeng Yan^2BDE, Darcy A. Kerr^2BDE, Muhammad Z. Afzal^1ABCE, Keisuke Shirai^1ADEF

DOI: 10.12659/AJCR.938537

Am J Case Rep 2023; 24:e938537

Authors information Article notes Copyright and License information

Background Case Reports Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 20. Case 7: (A) PET/CT obtained on May 30, 2019, showing a highly-FDG-avid 2.5-cm right lower lung nodule suspicious for primary lung malignancy versus metastasis. (B) PET/CT obtained on August 27, 2020, showing no evidence of recurrent or metastatic melanoma.

Back to the Article

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Your Privacy